Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C).

Overview
Research
Identity
Additional Document Info
View All

authors

Namrata Singh, MD MSCI
Madhira, Vithal
Hu, Chen
Olex, Amy L
Bergquist, Timothy
Fitzgerald, Kathryn C
Huling, Jared D
Patel, Rena C
Singh, Jasvinder A

publication date

January 1, 2022

published in

Seminars in arthritis and rheumatism Journal

has subject area